Position
Chief Executive Officer
Company
ME Therapeutics Holdings
VancouverBiotechnologyHealth CareTherapeuticsDescription
ME Therapeutics Holdings Inc. is pleased to announce the appointment of Karim Lalji as Chief Business Officer. Karim is an exceptional leader in the life sciences sector and his strategic vision and experience driving commercial transactions will be an invaluable asset to the Company as they continue their growth.
Quick answer
ME Therapeutics Appoints Karim Lalji as Chief Business Officer (October 25, 2024). ME Therapeutics Holdings is based in Vancouver, British Columbia, Canada.
- What did ME Therapeutics Holdings announce on October 25, 2024?
- ME Therapeutics Holdings Inc. is pleased to announce the appointment of Karim Lalji as Chief Business Officer. Karim is an exceptional leader in the life sciences sector and his strategic vision and experience driving commercial transactions will be an invaluable asset to the Company as they continue their growth.
- What does ME Therapeutics Holdings do?
- ME Therapeutics is a preclinical stage biotechnology company based in Vancouver, focused on the discovery and development of novel immuno-oncology therapeutics targeting immune suppression in cancer.
- Where is ME Therapeutics Holdings based?
- ME Therapeutics Holdings is based in Vancouver, British Columbia, Canada.
- Which similar companies made leadership changes around the same time?
- RYNE Biotechnology (October 23, 2024), LigaChem Biosciences (October 23, 2024), Parexel (October 22, 2024) and Arialys Therapeutics (October 22, 2024) also announced leadership changes within 45 days of ME Therapeutics Holdings.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Kenai Therapeutics Appoints Derek Hei as Chief Technology Officer (October 23, 2024)
- LigaChem Biosciences Appoints Rodrigo Ruiz Soto as Chief Medical Officer (CMO) (October 23, 2024)
- Parexel Appoints Keri Mattox as Chief Business Officer (October 22, 2024)
- Arialys Therapeutics Appoints Dr. Sankalp Gokhale as Chief Medical Officer (October 22, 2024)
- Actinogen Medical Appoints Andrew Udell as Chief Commercial Officer reporting to CEO Dr Steven Gourlay (October 29, 2024)
- HuidaGene Therapeutics Appoints TJ Cradick, PhD as Chief Technology Officer (October 21, 2024)
Who to call at ME Therapeutics Holdings, and when
A new leader at ME Therapeutics Holdings brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day ME Therapeutics Holdings raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ME Therapeutics Holdings, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ME Therapeutics Holdings. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ME Therapeutics Holdings changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
ME Therapeutics Holdings changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.